Compounds that induce ferroptic cell death
AssigneeThe Board of Trustees of the University of Illinois
InventorsPaul J. Hergenrother, Evijola Llabani
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Board of Trustees of the University of Illinois
InventorsPaul J. Hergenrother, Evijola Llabani
Estimating the term…
The diterpene natural product pleuromutilin was subjected to reaction sequences focused on creating ring system diversity in few synthetic steps. This effort resulted in a collection of compounds with previously unreported ring systems, providing a novel set of structurally diverse and highly complex compounds suitable for screening in a variety of different settings. Biological evaluation identified the novel compound ferroptocide, a small molecule that rapidly and robustly induces ferroptotic death of cancer cells. Target identification efforts and CRISPR knockout studies reveal that ferroptocide is an inhibitor of thioredoxin, a key component of the antioxidant system in the cell. Ferroptocide positively modulates the immune system in a murine model of breast cancer and will be a useful tool to study the utility of pro-ferroptotic agents for treatment of cancer.
A compound of Formula I:
Dependencies are inferred from the claim text.